When evaluating healthcare ETFs like XLV, consider these four key metrics to make informed investment decisions:

  1. Expense Ratios: XLV has a low expense ratio of 0.08%, making it one of the most cost-effective options compared to peers like VHT (0.09%) and XBI (0.35%). Lower fees mean more of your returns stay in your pocket.
  2. Historical Volatility: XLV focuses on large-cap healthcare stocks, offering steadier performance with less price fluctuation compared to biotech-heavy funds like XBI, which tend to be more volatile.
  3. Tracking Difference: XLV closely mirrors its benchmark (Health Care Select Sector Index), ensuring reliable exposure to the sector. Factors like expense ratios and portfolio sampling can impact tracking accuracy across funds.
  4. Portfolio Overlap: Many healthcare funds, including XLV, share top holdings like Johnson & Johnson and Pfizer. This overlap can lead to concentration risk, especially if you hold multiple funds.

Quick Comparison

Fund Name Expense Ratio Focus Area Volatility Top Holdings Overlap
XLV 0.08% Large-cap healthcare Low High
VHT 0.09% Broad healthcare Moderate High
XBI 0.35% Biotech High Low

Key Takeaway: XLV is a low-cost, stable option for broad healthcare exposure. However, consider diversification and overlap when combining it with other funds.

5 Best Healthcare ETFs (XLV, VHT, + More)

XLV

XLV Fund Overview and Key Metrics

The Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund (ETF) designed to provide broad exposure to the healthcare sector. It tracks the Health Care Select Sector Index, using a market-cap-weighted approach to include a diverse range of healthcare companies.

Investment Strategy and Top Holdings

XLV follows a passive investment strategy by mirroring the healthcare segment of the S&P 500. Companies are selected and weighted automatically based on their market value, ensuring the fund stays aligned with the index's structure.

The fund’s portfolio typically includes some of the largest and most influential players in the healthcare industry. Major healthcare services firms often take up significant positions, while well-established pharmaceutical and healthcare product companies round out the list. Because of this focus on large-cap stocks, XLV’s performance is closely tied to the success of these industry leaders. This strategy aligns well with the fund's operational strengths, which are highlighted below.

Fund Size, Fees, and Dividend Yield

As one of the largest ETFs dedicated to healthcare, XLV benefits from a substantial asset base. This translates to high liquidity and tight bid-ask spreads, making it an efficient choice for investors.

The fund is also known for its low expense ratio, which helps investors retain more of their returns. Additionally, XLV provides a moderate dividend yield, with dividends distributed quarterly. This combination of regular income and the potential for capital growth makes it an attractive option for many investors.

Recent Performance Data

XLV has shown consistent performance in recent years, supported by the strong fundamentals of the healthcare sector. Its returns reflect a mix of capital appreciation and steady dividend income, while the fund typically experiences less volatility than sectors like technology. Growth drivers, such as advancements in pharmaceuticals and demographic trends like an aging population, further contribute to its performance.

However, investors should be mindful of potential risks, including regulatory changes and pressures on drug pricing, which can cause short-term market fluctuations.

Expense Ratio Comparison: XLV vs Healthcare Fund Peers

Expense ratios play a crucial role in shaping long-term investment returns. These annual fees are deducted directly from a fund's assets, which means lower-cost funds tend to be more appealing for those focused on maximizing returns over time.

Healthcare Fund Expense Ratios

When it comes to healthcare ETFs, XLV stands out as one of the most affordable options. With an expense ratio of just 0.08%, it provides broad exposure to the healthcare sector at a very low cost. Here's a quick look at how XLV compares to another popular healthcare ETF:

Fund Name Expense Ratio Issuer
Health Care Select Sector SPDR Fund (XLV) 0.08% State Street
Vanguard Health Care ETF (VHT) 0.09% Vanguard

While XLV’s expense ratio is only 0.01% lower than VHT’s, both funds are far more economical than the industry average, which typically ranges between 0.3% and 0.9%. This small difference in fees may seem negligible, but it can add up over time, especially for long-term investors.

How Fees Affect Long-Term Returns

Even minor fee differences can significantly impact your returns when compounded over years. Let’s break it down with an example:

  • A $10,000 investment earning a 7% annual return would lose $8 annually to XLV’s fee, compared to $9 annually with VHT.
  • Over 20 years, that 0.01% difference could translate into meaningful savings, preserving more of your investment's growth.

For those curious about how fees affect their portfolios, tools like Mezzi’s fee calculator can be a game-changer. This tool allows you to model different scenarios and see the real dollar impact of choosing lower-cost funds. It’s a great way to visualize how minimizing fees helps retain more of your investment returns over time.

When comparing healthcare funds with similar strategies and holdings, the choice often comes down to fees. In most cases, the fund with the lower expense ratio provides better value for long-term investors.

Historical Volatility: Risk Comparison Across Healthcare Funds

After examining expense ratios, tracking differences, and portfolio overlap, evaluating volatility adds another layer to understanding fund risk. By analyzing price fluctuations, you can gauge the level of risk a fund introduces to your portfolio. Healthcare funds, in particular, can exhibit varying degrees of volatility depending on their holdings, market conditions, and the companies they invest in.

Volatility Data: Standard Deviation and Beta

Two key metrics often used to measure volatility are standard deviation and beta:

  • Standard deviation reflects how much a fund's returns vary from its average performance. A higher standard deviation means more significant price swings, while a lower one indicates steadier, more predictable performance.
  • Beta, on the other hand, measures a fund's sensitivity to the broader market. A beta above 1.0 implies the fund is more volatile than the market, while a beta below 1.0 suggests relatively milder fluctuations.

Healthcare funds tend to show moderate standard deviation and a beta below 1.0. This combination highlights the sector's defensive nature, balanced with the risks inherent in market exposure. For example, a typical healthcare fund might experience smaller market swings compared to more volatile sectors, making it a potentially stabilizing choice within a diversified portfolio. These metrics provide a clearer picture of a fund's risk profile, helping investors make more informed decisions.

Risk Management Considerations

While healthcare funds are generally seen as stable, they are not immune to market pressures. For example, during the early stages of the COVID-19 pandemic, even defensive sectors like healthcare faced significant downturns before eventually recovering.

To manage such risks, tools like Mezzi's X-Ray can be invaluable. This tool analyzes fund holdings to identify potential concentrations of risk. For instance, it can uncover instances where multiple funds in your portfolio are heavily invested in the same large-cap pharmaceutical or biotech companies. This type of overlap is common in healthcare funds and can affect the diversification of your overall investment strategy.

Tracking Difference: How Well Funds Follow Their Benchmarks

After analyzing fees and volatility, the next step in evaluating a fund is to assess how well it tracks its benchmark. Tracking difference measures how closely a fund's returns align with its benchmark. Since perfect alignment is rare, understanding these deviations helps determine if a healthcare fund is delivering the exposure you're paying for.

Tracking Difference Measurements

Healthcare ETFs vary in how accurately they track their benchmarks, influenced by factors like expense ratios, the number of holdings, and the specific index they aim to replicate. Here's a comparison of key metrics for some popular healthcare funds:

Fund Expense Ratio Holdings Count Benchmark Index
XLV 0.08% N/A Health Care Select Sector Index
VHT 0.10% 421 MSCI US IMI 25/50 Health Care Index
FHLC 0.08% 364 MSCI US IMI 25/50 Health Care Index
IYH 0.40% 109 Dow Jones U.S. Health Care Index
XBI 0.35% N/A S&P Biotechnology Select Industry Index

This table highlights differences in fund structure that can influence tracking performance. For instance, while both VHT and FHLC track the same MSCI index, they hold different numbers of securities. On the other hand, IYH follows a completely different benchmark and maintains a more concentrated portfolio. These distinctions, when combined with earlier metrics, provide a more complete view of each fund's performance.

Why Tracking Error Occurs in ETFs

Perfectly replicating index performance is a challenge for ETFs due to several factors. Tracking errors can arise from expense ratios, portfolio sampling, or cash drag, all of which can cause slight discrepancies between a fund's returns and its benchmark.

  • Expense Ratios: These fees reduce the fund's net returns compared to the benchmark.
  • Portfolio Sampling: Instead of holding every stock in the index, some funds use a sampling strategy, which can lead to variations.
  • Cash Drag: Cash reserves held by funds for liquidity purposes may slightly impact returns.

Tools like Mezzi's aggregation platform help monitor these differences, allowing for precise portfolio adjustments when needed.

Portfolio Overlap: Shared Holdings Between Healthcare Funds

When building a healthcare-focused portfolio across multiple funds, it's crucial to analyze each fund's holdings to avoid excessive concentration risk.

Holdings Overlap Analysis

Funds like XLV often mirror other broad healthcare ETFs in their focus on large-cap pharmaceutical and biotechnology stocks. This overlap is particularly evident in their top holdings:

  • Johnson & Johnson consistently ranks as a top holding in XLV, VHT, and FHLC.
  • UnitedHealth Group carries significant weight across funds due to its massive market cap.
  • Pfizer and AbbVie also frequently appear in multiple healthcare ETFs.

However, the overlap diminishes when comparing XLV to more specialized funds. For example, XBI leans toward smaller biotech firms, though both XBI and XLV might include major biotech names like Gilead Sciences and Amgen. Similarly, IYH, which tracks the Dow Jones U.S. Health Care Index, shares XLV's large-cap focus but diverges in mid- and small-cap exposures. Understanding these nuances is key to assessing diversification across your portfolio.

Diversification Effects

Excessive overlap among funds can lead to concentration risk, where multiple funds hold the same top stocks. This not only increases redundancy in fees but also amplifies risk during sector-specific downturns, as correlated holdings are likely to move in tandem.

Beyond individual stocks, subsector concentration is another concern. Many broad healthcare funds heavily emphasize pharmaceutical companies due to their market dominance, often at the expense of other subsectors like medical devices, healthcare services, or smaller biotech firms. As a result, what appears to be a diversified portfolio may, in reality, be overly tilted toward one segment of the healthcare sector.

Tools like Mezzi's X-Ray tool can help identify these hidden overlaps by analyzing portfolio holdings at the company level. This insight is invaluable in avoiding scenarios where a significant portion of your portfolio is unintentionally allocated to a single stock through overlapping fund positions.

For instance, pairing XLV with a dedicated pharmaceutical fund could result in excessive exposure to companies like Johnson & Johnson or Pfizer, while leaving gaps in emerging healthcare subsectors. By identifying these overlaps, you can make more deliberate allocation choices, ensuring genuine diversification and avoiding redundant fees.

Key Takeaways for Healthcare Fund Selection

Selecting the right healthcare fund means finding the right balance between cost, risk, and diversification. For cost-conscious investors, XLV's low 0.08% fee stands out as a highly efficient option, especially when compared to funds like FSPHX, which has a higher expense ratio of 0.63%. VHT, with its 0.09% fee, and specialized funds like XBI (0.35%) also offer moderate fee structures. Over time, even small differences in fees can significantly impact long-term returns.

"Expense ratios are an important factor in the return of an ETF and in the long term, cheaper funds can significantly outperform their more expensive counterparts, other things remaining the same." - Zacks Equity Research

Risk is another critical factor to weigh. A fund like XLV, which focuses on large-cap healthcare companies, provides broader stability. On the other hand, biotech-focused funds may offer higher growth potential but often come with greater volatility. Aligning your fund choices with your risk tolerance and long-term goals is essential.

Diversification is equally important when constructing your portfolio. Investing in multiple healthcare funds without careful planning can lead to overlapping holdings, especially in major companies commonly found across various funds. Tools such as Mezzi's X-Ray feature can help identify these overlaps, ensuring your portfolio remains well-diversified rather than overly concentrated in a few key stocks.

Lastly, tracking efficiency is a vital consideration. A fund with low fees might still underperform if it has significant tracking errors, making it essential to evaluate both cost and how closely the fund mirrors its benchmark.

A solid healthcare fund strategy blends low fees with thoughtful diversification. XLV's low-cost structure and broad sector exposure make it an excellent core holding, while carefully selected specialized funds can add value if they provide real diversification. By addressing fees, risk, potential overlaps, and tracking accuracy, you can build a well-rounded and efficient investment approach.

FAQs

How does XLV's expense ratio compare to other healthcare ETFs, and why does it matter for long-term investments?

The expense ratio of XLV is 0.08%, which makes it one of the more affordable options among healthcare ETFs. Why does this matter? Lower expense ratios mean you pay less in fees, leaving more of your money to grow over time. Over the long haul, especially when compounded, this can make a noticeable difference in your investment returns.

When evaluating healthcare ETFs, paying attention to expense ratios is a smart move. Even small fee differences can accumulate over the years, so low-cost funds like XLV are a solid choice for investors looking to maximize their portfolio's efficiency while keeping costs in check.

What risks come with high portfolio overlap in healthcare ETFs, and how can I reduce them?

High portfolio overlap in healthcare ETFs can expose you to concentration risk, meaning a large chunk of your investment might rely heavily on just a few companies or a specific sector. This can leave your portfolio more susceptible to sharp market fluctuations or downturns within the healthcare industry.

To mitigate this, look into ETFs with lower overlap or those that offer a wider variety of holdings. Spreading your investments across different funds can help balance your risk and strengthen the overall stability of your portfolio.

How does XLV's tracking difference affect its performance, and what causes these variations?

The performance of XLV can occasionally diverge from its benchmark index due to what's known as a tracking difference. This happens because of factors like expense ratios, which can slightly chip away at returns, as well as external influences such as trading costs, the timing of dividends, or delays in rebalancing the portfolio.

Although these differences are generally minor, they can accumulate over time, particularly for long-term investors. Being aware of these variations allows you to assess how well XLV stays aligned with its benchmark and whether it supports your investment objectives.

Related Blog Posts

Table of Contents

Text Link

Book Free Consultation

Walk through Mezzi with our team, review your current situation, and ask any questions you may have.

Book Free Consultation
Ask ChatGPT about Mezzi